Browse Catalog by Subject
Catalog|Healthcare and Pharmaceuticals (39385 reports)
Additional Filter:
Biotechnology ( 4613 )
Medical Devices ( 8213 )
Healthcare ( 12454 )
Pharmaceuticals ( 27981 )

Sort by:


251 Angiotech Pharmaceuticals, Inc. (ANPMF) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
252 Axis-Shield plc - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
253 BioAlliance Pharma SA (BIO) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
254 Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
255 BioElectronics Corporation (BIEL) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
256 Bioject Medical Technologies Inc. (BJCT) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
257 BioLineRx, Ltd. (BLRX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
258 BioMimetic Therapeutics, Inc. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
259 Cardinal Health, Inc. (CAH) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
260 Ceapro Inc. (CZO) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
261 Cellavision AB (CEVI) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
262 Coltene Holding AG (CLTN) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
263 Cyprotex PLC (CRX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
264 DARA BioSciences, Inc. (DARA) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
265 DJO Finance LLC - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
266 Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
267 Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
268 Intercell AG (ICLL) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
269 Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
270 LeMaitre Vascular, Inc. (LMAT) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
271 Lightlake Therapeutics Inc. (LLTP) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
272 Mast Therapeutics, Inc. (MSTX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
273 Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
274 MMRGlobal, Inc. (MMRF) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
275 Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125